Participant-reported personal utility of genetic testing for Parkinson's disease and interest in clinical trial participation

dc.contributor.authorOas, Hannah
dc.contributor.authorCook, Lola
dc.contributor.authorSchwantes-An, Tae-Hwi
dc.contributor.authorWalsh, Laurence E.
dc.contributor.authorWills, Anne-Marie
dc.contributor.authorMata, Ignacio F.
dc.contributor.authorNance, Martha A.
dc.contributor.authorBeck, James C.
dc.contributor.authorNaito, Anna
dc.contributor.authorMarder, Karen
dc.contributor.authorAlcalay, Roy N.
dc.contributor.authorVerbrugge, Jennifer
dc.contributor.departmentMedical and Molecular Genetics, School of Medicine
dc.date.accessioned2024-11-18T14:16:55Z
dc.date.available2024-11-18T14:16:55Z
dc.date.issued2024-10-25
dc.description.abstractGenetic testing for Parkinson's disease (PD) is infrequently performed due to perceptions of low utility. We investigated the personal utility in PD GENEration and how results lead to enrollment in additional research studies. Participants (n = 972) underwent genetic testing, results disclosure, genetic counseling, and completed a survey examining the perceived personal utility of their results and interest in participating in additional studies. Most participants found their genetic test results useful, including satisfying curiosity (81%), feeling good about helping the medical community (80%), and having information to share with family (77%). There were no significant differences in responses based on result type. Forty-five percent of participants expressed interest in participating in research studies; whereas 16% of participants confirmed enrollment. Our results suggest that participants find personal utility in genetic testing regardless of results. Although participants may be interested in enrolling in additional research, they may need support and resources.
dc.eprint.versionFinal published version
dc.identifier.citationOas H, Cook L, Schwantes-An TH, et al. Participant-reported personal utility of genetic testing for Parkinson's disease and interest in clinical trial participation. NPJ Parkinsons Dis. 2024;10(1):202. Published 2024 Oct 25. doi:10.1038/s41531-024-00805-z
dc.identifier.urihttps://hdl.handle.net/1805/44585
dc.language.isoen_US
dc.publisherSpringer Nature
dc.relation.isversionof10.1038/s41531-024-00805-z
dc.relation.journalNPJ Parkinson's Disease
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectParkinson's disease
dc.subjectOutcomes research
dc.subjectRisk factors
dc.subjectGenetic testing
dc.titleParticipant-reported personal utility of genetic testing for Parkinson's disease and interest in clinical trial participation
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Oas2024Participant-CCBY.pdf
Size:
611.78 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: